Photo of Tanja Pejovic, M.D., Ph.D.

Tanja Pejovic M.D., Ph.D.

Dr. Pejovic has advanced training in treating all cancers of the female reproductive organs (gynecologic cancers). Her research interest in how ovarian cancer develops in the body's cells has given her a deep understanding of this disease. While she continues to work with other OHSU doctors and scientists on applying the latest scientific discoveries to patient care, Dr. Pejovic is also interested in holistic approaches to cancer care and is pursuing formal training in cancer, aging and self-healing abilities.

Education

  • M.D., University of Belgrade, 0 0 1984
  • Ph.D., University of Lund, 0 0 1991
  • Residency:

    • Gynecologic oncology, University of Lund, 1995
  • Fellowship:

    • Yale University School of Medicine, 2003
  • Certifications:

    • American Board of Obstetrics and Gynecology, 2004

Memberships and associations

  • Fellow, American Congress of Obstetricians and Gynecologists

Publications

  • "Drugging homologous recombination : Back to the future." Future Medicinal Chemistry  In: , Vol. 10, No. 11, 01.06.2018, p. 1279-1281.
  • "Professionally responsible management of gynecologic cancer in pregnancy when clinical resources are unavoidably limited." Unknown Journal  In: , 30.01.2018.
  • "High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer." Gynecologic Oncology In: , Vol. 146, No. 1, 01.07.2017, p. 153-160.
  • "A recurrent endometrial stromal sarcoma harbors the novel fusion JAZF1-BCORL1." Gynecologic Oncology Reports  In: , Vol. 20, 01.05.2017, p. 51-53.
  • "Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer." Nature Genetics  In: , Vol. 49, No. 5, 01.05.2017, p. 680-691.
  • "Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma." Gynecologic Oncology In: , Vol. 145, No. 1, 01.04.2017, p. 78-87.
  • "No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival." Cancer Epidemiology Biomarkers and Prevention In: , Vol. 26, No. 3, 01.03.2017, p. 420-424.
  • "Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci." British Journal of Cancer  In: , Vol. 116, No. 4, 14.02.2017, p. 524-535.
  • "Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma." Gynecologic Oncology In: , Vol. 144, No. 2, 01.02.2017, p. 329-335.
  • "Predictors of pretreatment CA125 at ovarian cancer diagnosis : a pooled analysis in the Ovarian Cancer Association Consortium." Cancer Causes and Control In: , 03.01.2017, p. 1-10.
  • "Pregnancy after treatment for adult granulose cell tumor : A case report." Clinical and Experimental Obstetrics and Gynecology In: , Vol. 44, No. 6, 01.01.2017, p. 964-965.
  • "Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer." Gynecologic Oncology In: , 2017.
  • "Salvage chemotherapy with taxane and platinum for women with recurrent uterine carcinosarcoma." Gynecologic Oncology In: , 2017.
  • "Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci." Oncotarget  In: , Vol. 8, No. 39, 2017, p. 64670-64684.
  • "Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus." Nature Communications  In: , Vol. 7, 12675, 07.09.2016.
  • "PALB2, CHEK2 and ATM rare variants and cancer risk : Data from COGS." Journal of Medical Genetics  In: , 02.09.2016.
  • "Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types." Cancer Discovery  In: , Vol. 6, No. 9, 01.09.2016, p. 1052-1067.
  • "Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma." Annals of Oncology In: , Vol. 27, No. 7, mdw161, 01.07.2016, p. 1257-1266.
  • "Adult body mass index and risk of ovarian cancer by subtype : a Mendelian randomization study." International journal of epidemiology  In: , Vol. 45, No. 3, 01.06.2016, p. 884-895.
  • "No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer." Gynecologic Oncology  In: , Vol. 141, No. 2, 01.05.2016, p. 386-401.
  • "Nestin : A biomarker of aggressive uterine cancers." Gynecologic Oncology  In: , Vol. 140, No. 3, 01.03.2016, p. 503-511.
  • "Investigation of exomic variants associated with overall survival in ovarian cancer." Cancer Epidemiology Biomarkers and Prevention In: , Vol. 25, No. 3, 01.03.2016, p. 446-454.
  • "BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers." Journal of the National Cancer Institute In: , Vol. 108, No. 2, djv315, 01.02.2016.
  • "Gynecological oncologic emergencies."   Oncologic Emergency Medicine: Principles and Practice. Springer International Publishing, 2016. p. 351-358.
  • "Evidence of a genetic link between endometriosis and ovarian cancer." Fertility and Sterility In: , Vol. 105, No. 1, 2016, p. 35-43e10.
  • "Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer." Oncotarget  In: , Vol. 7, No. 6, 2016, p. 6353-6368.
  • "Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer." Oncotarget  In: , Vol. 7, No. 43, 2016, p. 69097-69110.
  • "Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility : Results from a large-scale collaboration." Oncotarget  In: , Vol. 7, No. 45, 2016, p. 72381-72394.
  • "Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes : Findings from the Ovarian Cancer Association Consortium." Clinical Cancer Research  In: , Vol. 21, No. 23, 01.12.2015, p. 5264-5276.
  • "Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk." Genetic Epidemiology In: , Vol. 39, No. 8, 01.12.2015, p. 689-697.

Additional information

Edit profile